Escherichia coli and pseudomonas aeruginosa eradication by nano-penicillin G

dc.contributor.authorMacedo Fernandes, Margarida Maria
dc.contributor.authorIvanova, Kristina Dimitrova
dc.contributor.authorFrancesko, Antonio
dc.contributor.authorRivera, Diana
dc.contributor.authorTorrent Burgués, Juan
dc.contributor.authorMendoza Gómez, Ernesto
dc.contributor.authorTzanov, Tzanko
dc.contributor.groupUniversitat Politècnica de Catalunya. GBMI - Grup de Biotecnologia Molecular i Industrial
dc.contributor.otherUniversitat Politècnica de Catalunya. Departament d'Enginyeria Química
dc.contributor.otherUniversitat Politècnica de Catalunya. Departament de Física
dc.date.accessioned2016-09-21T11:43:01Z
dc.date.available2017-10-03T00:30:10Z
dc.date.issued2016-06-09
dc.description.abstractThe transformation of penicillin G into nano/micro-sized spheres (nanopenicillin) using sonochemical technology was explored as a novel tool for the eradication of Gram-negative bacteria and their biofilms. Known by its effectiveness only against Gram-positive microorganisms, the penicillin G spherization boosted the inhibition of the Gram-negative Pseudomonas aeruginosa 10-fold (from 0.3 to 3.0 log-reduction) and additionally induced 1.2 log-reduction of Escherichia coli growth. The efficient penetration of the spheres within a Langmuir monolayer sustained the theory that nanopenicillin is able to cross the membrane and reach the periplasmic space in Gram-negative bacteria where they inhibit the ß-lactam targets: the transferases that build the bacteria cell wall. Moreover, it considerably suppressed the growth of both bacterial biofilms on a medically relevant polystyrene surface, leaving majority of the adhered cells dead compared to the treatment with the non-processed penicillin G. Importantly, nanopenicillin was found innocuous towards human fibroblasts at the antibacterial-effective concentration
dc.description.peerreviewedPeer Reviewed
dc.description.versionPostprint (published version)
dc.format.extent9 p.
dc.identifier.citationMacedo, M.M., Ivanova, K., Francesko, A., Rivera, D., Torrent, J.; Torrent-Burgués, J., Mendoza, E., Tzanov, T. Escherichia coli and pseudomonas aeruginosa eradication by nano-penicillin G. "Nanomedicine: nanotechnology, biology and medicine", 9 Juny 2016, vol. 12, núm. 7, p. 2061-2069.
dc.identifier.doi10.1016/j.nano.2016.05.018
dc.identifier.issn1549-9634
dc.identifier.urihttps://hdl.handle.net/2117/90102
dc.language.isoeng
dc.relation.publisherversionhttp://www.nanomedjournal.com/article/S1549-9634(16)30065-X/abstract
dc.rights.accessOpen Access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subjectÀrees temàtiques de la UPC::Enginyeria química
dc.subject.lcshBioengineering
dc.subject.lcshNanoparticles--Therapeutic use
dc.subject.lemacBioenginyeria
dc.subject.lemacNanopartícules -- Ús terapèutic
dc.subject.otherPenicillin G
dc.subject.otherSonochemistry
dc.subject.otherNano/Microspheres
dc.subject.otherNano-bio interactions
dc.subject.otherAntibacterial
dc.subject.otherAntibiofilm
dc.titleEscherichia coli and pseudomonas aeruginosa eradication by nano-penicillin G
dc.typeArticle
dspace.entity.typePublication
local.citation.authorMacedo, M.M., Ivanova, K., Francesko, A., Rivera, D., Torrent, J.; Torrent-Burgués, J., Mendoza, E., Tzanov, T.
local.citation.endingPage2069
local.citation.number7
local.citation.publicationNameNanomedicine: nanotechnology, biology and medicine
local.citation.startingPage2061
local.citation.volume12
local.identifier.drac18768186

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
revised manuscript_Tzanov_3.docx
Mida:
1.78 MB
Format:
Microsoft Word XML